ICUIICU MEDICAL INC/DE
Surgical & Medical Instruments & Apparatus
- Revenue
- $2.2B
- 6.3% YoY
- Operating margin
- 1.9%
- 6.4% YoY
- EBITDA
- $244M
- 7.2% YoY
- Market cap
- —
- Employees
- —
- Net debt / EBITDA
- 4.2×
- $1.0B net debt
- AI in 10-K
- —
Red flags 0 of 9
- TSR below peersClear—3+ of last 5 years
- High CEO pay despite TSRClear—Median CEO pay ≥ $15M and TSR flag
- Active 13DClear0 filingsActive-intent 13D in 18 months
- Net insider sellingClear$0 netNet sales over $10M in 12 months
- Earnings not backed by cashClear246× net incomeCash flow under 80% of net income
- Dilutive SBCClear2% of revenueOver 10% of revenue
- Payouts exceed cash flowClear5% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyClear37% of assetsOver 40% of assets
- Shareholder dissentClear—Any vote under 80% support
Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $1.3B | $2.3B | $2.3B | $2.4B | $2.2B | 6.3% |
| Operating income | $123M | −$43M | $23M | $43M | $43M | 0.3% |
| Net income | $103M | −$74M | −$30M | −$118M | $732K | 101% |
| Operating cash flow | $268M | −$62M | $166M | $204M | $180M | 12% |
| Capex | $69M | $90M | $84M | $79M | $88M | 11% |
| Stock-based comp | $27M | $36M | $41M | $47M | $56M | 19% |
| Buybacks | $8M | $11M | $9M | $12M | $9M | 27% |
Deal filings
None.
13D filers
None on file.
Insider trading
No open-market trades in the last 12 months.
Pay vs performance
No pay-versus-performance disclosure yet.